Cytokinetics therapeutics
WebApr 6, 2024 · Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Its lead drug candidate from its cardiac muscle contractility program, omecamtiv mecarbil, is … WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … Cytokinetics is a late-stage biopharmaceutical company focused on … Cytokinetics, Inc. does not by its reference above or distribution imply its … Cytokinetics is a late-stage biopharmaceutical company focused on … SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of … The key to muscle function is contraction. The principal functionality of muscle is … Heart failure affects 64 million people worldwide, hospitalizes more Americans …
Cytokinetics therapeutics
Did you know?
WebHeadquarters United States of America. Address ., 280 East Grand Avenue, South San Francisco, California, 94080. Website cytokinetics.com. Telephone 1 650 6243000. No of Employees 253. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX.
WebNov 28, 2006 · Cytokinetics is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The cytoskeleton is a complex biological infrastructure that plays a fundamental role within every human cell. WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential …
WebCytokinetics is dedicated to the discovery, development and commercialization of a novel class of therapeutics resulting from its leadership position in the emerging field of cytoskeletal pharmacology. Use the CB Insights Platform to explore Cytokinetics's full … WebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) . Shares of the company have moved down 20.5% compared ...
WebThis Amendment No. 6 to the Agreement (this “Amendment No. 6”) is entered into as of June 11, 2013 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a ...
WebApr 6, 2024 · The main competitors of Cytokinetics include IVERIC bio (ISEE), Reata Pharmaceuticals (RETA), Zai Lab (ZLAB), Maravai LifeSciences (MRVI), Amicus Therapeutics (FOLD), PTC Therapeutics (PTCT), ACADIA Pharmaceuticals (ACAD), Cerevel Therapeutics (CERE), Bausch Health Companies (BHC), and Ultragenyx … hogwarts female graphornWeb2 days ago · Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for … hub city pt25215sWebApr 11, 2024 · 12 analysts have issued twelve-month price targets for Cytokinetics' shares. Their CYTK share price forecasts range from $15.00 to $80.00. On average, they expect the company's stock price to reach $56.21 in the next year. This suggests a possible upside of 54.4% from the stock's current price. View analysts price targets for CYTK or view top ... hub city propertiesWebApr 6, 2024 · Cytokinetics started at overweight with $58 stock price target at J.P. Morgan. Dec. 10, 2024 at 6:59 a.m. ET by Tomi Kilgore. Biotech and Pharma Cytokinetics Stock Is Surging. Heart-Drug Results ... hub city publishingWebCytokinetics 14,180 followers on LinkedIn. Empowering Muscle Empowering Lives Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing ... hogwarts ferdinand prattWebCytokinetics is a biopharmaceutical company developing therapies for debilitating diseases. South San Francisco, California, United States 251-500 Post-IPO Debt Public cytokinetics.com 1,449 Highlights Stock … hogwarts female teacher with brown hair artWebMar 10, 2024 · Cytokinetics has an analyst consensus of Strong Buy, with a price target consensus of $61.31, a 56.7% upside from current levels. In a report issued on February 28, Raymond James also maintained... hogwarts female uniform